Skip to content

Media

For the latest Napp news, press releases approved for communication with medical press and media, please visit:

mundipharma.com/media

Archived Press Releases for medical and trade media

© 2025 NAPP PHARMACEUTICALS LIMITED. DOP June 2024 UK-CORP-2200004

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”

Napp
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.